Ticker Sage

Form 4 · EMR

Emerson Sr VP Michael Tang reports an award of 34,450 shares

Part of a grouped insider digest: see all related filings with totals →

Michael Tang, Emerson's Sr VP, Secy & Chf Leg Ofc, filed a Form 4 on Nov 4, 2026 at 4:41 PM ET reporting transactions between Nov 2, 2026 and Nov 3, 2026.

The filing reports 34,450 shares in a grant or award (code A); and 13,774 shares withheld to pay the exercise price or tax (code F).

After these transactions, the filing lists 49,961 shares held directly.

Effect on holdings

Taken together, the rows reported here raised Michael Tang's directly held shares by 70.6%, from 29,285 to 49,961.

Reporting person

Transactions as reported

DateCodeSecuritySharesPriceAcquired or disposedHeld afterOwnership
2026-11-02ACommon Stock28,223Acquired57,508Direct
2026-11-02FCommon Stock12,701$167.95Disposed44,807Direct
2026-11-02ACommon Stock6,227Acquired51,034Direct
2026-11-03FCommon Stock1,073$166.43Disposed49,961Direct

Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.

Source

Emerson company file → · More Emerson filings

Disclosures

Editor holdings in EMR
The editor holds no position in Emerson (EMR). As of Nov 11, 2026.
Last updated
Nov 4, 2026

A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold EMR.